Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 34,285 | 25,096 | 28,584 | 31,693 | 26,896 |
| Operating Income | -34,285 | -25,096 | -28,584 | -31,693 | -26,896 |
| Other Income | 4,618 | 4,948 | 3,249 | 3,149 | 3,716 |
| Pre-tax Income | -29,667 | -20,148 | -25,335 | -28,544 | -23,180 |
| Net Income Continuous | -29,667 | -20,148 | -25,335 | -28,544 | -23,180 |
| Net Income | $-29,667 | $-20,148 | $-25,335 | $-28,544 | $-23,180 |
| EPS Basic Total Ops | -0.45 | -0.32 | -0.49 | -0.57 | -0.46 |
| EPS Basic Continuous Ops | -0.45 | -0.32 | -0.49 | -0.57 | -0.46 |
| EPS Diluted Total Ops | -0.45 | -0.32 | -0.49 | -0.57 | -0.46 |
| EPS Diluted Continuous Ops | -0.45 | -0.32 | -0.49 | -0.57 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.32 | -0.49 | -0.57 | -0.46 |
| EBITDA(a) | $-34,184 | $-25,344 | $-28,430 | $-31,664 | $-25,840 |